Unlike the apparent consistency of the data indicating that the β1-AR gene variant at position 389 modifies the response to β-AR-blocker therapy in heart failure,13-15 as with many genetic variants studied to date, the reported relationships between the functional Gly389Arg polymorphism of the β1-AR gene and heart failure have been inconsistent. The gene discussed is ADRB1; the disease is heart failure.